CA3218264A1 - Method for producing oligonucleic acid compound - Google Patents
Method for producing oligonucleic acid compound Download PDFInfo
- Publication number
- CA3218264A1 CA3218264A1 CA3218264A CA3218264A CA3218264A1 CA 3218264 A1 CA3218264 A1 CA 3218264A1 CA 3218264 A CA3218264 A CA 3218264A CA 3218264 A CA3218264 A CA 3218264A CA 3218264 A1 CA3218264 A1 CA 3218264A1
- Authority
- CA
- Canada
- Prior art keywords
- dimethylamino
- methoxy
- morpholin
- alkyl
- phosphory1
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
- C07F9/65616—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021076609 | 2021-04-28 | ||
| JP2021-076609 | 2021-04-28 | ||
| PCT/JP2022/019139 WO2022230954A1 (ja) | 2021-04-28 | 2022-04-27 | オリゴ核酸化合物の製造方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3218264A1 true CA3218264A1 (en) | 2022-11-03 |
Family
ID=83848560
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3218264A Pending CA3218264A1 (en) | 2021-04-28 | 2022-04-27 | Method for producing oligonucleic acid compound |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240254158A1 (https=) |
| EP (1) | EP4332111A4 (https=) |
| JP (1) | JP7825613B2 (https=) |
| KR (1) | KR20240004559A (https=) |
| CN (1) | CN117279926A (https=) |
| AU (1) | AU2022266379A1 (https=) |
| CA (1) | CA3218264A1 (https=) |
| WO (1) | WO2022230954A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3244382A1 (en) * | 2021-12-27 | 2025-02-26 | Nippon Shinyaku Co., Ltd. | PROCESS FOR THE PRODUCTION OF OLIGONUCLEIC ACID COMPOUNDS |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3398378B2 (ja) | 1989-12-20 | 2003-04-21 | アンチビラルス・インコーポレイテツド | リン含有キラルインターサブユニットリンケージを有する非電荷モルホリノ―基体ポリマー |
| WO2005028494A1 (ja) * | 2003-09-02 | 2005-03-31 | Takeshi Wada | ５'-ホスフィチル化モノマーおよびh-ホスホネートオリゴヌクレオチド誘導体の製造方法 |
| MX2010004955A (es) | 2007-11-15 | 2010-06-30 | Avi Biopharma Inc | Metodo de sintesis de oligomeros de morfolina. |
| JP5548852B2 (ja) | 2009-05-29 | 2014-07-16 | 国立大学法人東京農工大学 | 疎水性基結合ヌクレオシド、疎水性基結合ヌクレオシド溶液、及び疎水性基結合オリゴヌクレオチド合成方法 |
| RS55610B1 (sr) * | 2010-09-30 | 2017-06-30 | Nippon Shinyaku Co Ltd | Derivat morfolino nukleinske kiseline |
| EP2816053B1 (en) | 2012-02-17 | 2021-03-24 | Ajinomoto Co., Inc. | Base-protected oligonucleotide |
| EP2921499B1 (en) | 2012-11-14 | 2020-01-22 | Takeda Pharmaceutical Company Limited | Method for liquid-phase synthesis of nucleic acids |
| WO2014189142A1 (ja) * | 2013-05-24 | 2014-11-27 | 味の素株式会社 | モルフォリノオリゴヌクレオチドの製造方法 |
| JP6673211B2 (ja) | 2014-10-14 | 2020-03-25 | 味の素株式会社 | モルフォリノオリゴヌクレオチドの製造方法 |
| CN112384520B (zh) * | 2018-05-10 | 2024-06-11 | 日本新药株式会社 | 寡核苷酸化合物的制造方法 |
| US12012427B2 (en) * | 2019-10-31 | 2024-06-18 | Indian Association For The Cultivation Of Science | Synthesis of Fmoc-protected morpholino monomers and their use in the synthesis of morpholino oligomer |
| CA3161586A1 (en) * | 2019-11-13 | 2021-05-20 | Nippon Shinyaku Co., Ltd. | Method for producing oligonucleic acid compound |
| EP4059943A4 (en) * | 2019-11-13 | 2024-01-31 | Nippon Shinyaku Co., Ltd. | METHOD FOR PRODUCING OLIGONUCLEIC ACID COMPOUND |
-
2022
- 2022-04-27 US US18/288,057 patent/US20240254158A1/en active Pending
- 2022-04-27 AU AU2022266379A patent/AU2022266379A1/en active Pending
- 2022-04-27 EP EP22795867.5A patent/EP4332111A4/en active Pending
- 2022-04-27 CA CA3218264A patent/CA3218264A1/en active Pending
- 2022-04-27 WO PCT/JP2022/019139 patent/WO2022230954A1/ja not_active Ceased
- 2022-04-27 KR KR1020237039847A patent/KR20240004559A/ko active Pending
- 2022-04-27 CN CN202280031612.XA patent/CN117279926A/zh active Pending
- 2022-04-27 JP JP2023517605A patent/JP7825613B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN117279926A (zh) | 2023-12-22 |
| JP7825613B2 (ja) | 2026-03-06 |
| EP4332111A1 (en) | 2024-03-06 |
| AU2022266379A1 (en) | 2023-11-09 |
| WO2022230954A1 (ja) | 2022-11-03 |
| EP4332111A4 (en) | 2025-04-23 |
| JPWO2022230954A1 (https=) | 2022-11-03 |
| US20240254158A1 (en) | 2024-08-01 |
| KR20240004559A (ko) | 2024-01-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2813183C (en) | Morpholino nucleic acid derivatives | |
| DK2734208T3 (en) | PROCEDURES FOR SYNTHESIS OF FUNCTIONALIZED NUCLEIC ACIDS | |
| JP7394749B2 (ja) | オリゴ核酸化合物の製造方法 | |
| EP1117669A1 (en) | Antiviral purine derivatives | |
| KR20220049052A (ko) | Galnac 올리고뉴클레오티드 접합체를 위한 방법 | |
| JP2025128175A (ja) | オリゴ核酸化合物の製造方法 | |
| CA3218264A1 (en) | Method for producing oligonucleic acid compound | |
| JP2025111536A (ja) | オリゴ核酸化合物の製造方法 | |
| HK40102206A (en) | Method for producing oligonucleic acid compound | |
| CN119013048A (zh) | 一种药物连接体偶联物的制备方法及其中间体 | |
| HK40098710A (zh) | 低聚核酸化合物的制造方法 | |
| HK40072767A (en) | Method for producing oligonucleic acid compound | |
| HK40038624A (en) | Method for producing oligonucleic acid compound | |
| US20150175640A1 (en) | Forms of cidofovir | |
| HK40081457A (en) | Method for producing oligonucleic acid compound | |
| WO2024175051A1 (zh) | 一种疏水层析制备寡核苷酸的方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| D15 | Examination report completed |
Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D15-D126 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: EXAMINER'S REPORT Effective date: 20250128 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - RESPONSE TO EXAMINER'S REQUISITION Effective date: 20250305 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20250306 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 3RD ANNIV.) - STANDARD Year of fee payment: 3 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20250320 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT Effective date: 20250320 Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20250320 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT DETERMINED COMPLIANT Effective date: 20250507 |
|
| P13 | Application amended |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P13-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION AMENDED Effective date: 20250507 |
|
| D22 | Grant of ip right intended |
Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D22-D128 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: ALLOWANCE REQUIREMENTS DETERMINED COMPLIANT Effective date: 20260216 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20260216 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 4TH ANNIV.) - STANDARD Year of fee payment: 4 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20260226 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20260226 |